Tibor Bakacs: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs

Bakacs, Tibor, Safadi, Rifaat, Kovesdi, Imre

Journal:

Hepatology, Medicine and Policy

Year:

2018

Language:

english

File:

PDF, 607 KB

english, 2018

2

Angioimmunoblastic lymphadenopathy: A study of the function of lymphocyte populations

Dr. Tamás Garam, Mihály Bak, Tibor Bakács, Eszter Döbrentei, Győző Petrányi

Journal:

Year:

1981

Language:

english

File:

PDF, 763 KB

english, 1981

3

Interaction of the B95-8 and P3HR-1 substrains of epstein-barr virus (EBV) with peripheral human lymphocytes

Michael Steinitz, Tibor Bakács, George Klein

Journal:

International Journal of Cancer

Year:

1978

Language:

english

File:

PDF, 666 KB

english, 1978

4

Direct ADCC lysis of O,Rh-positive (R1R2) erythrocytes by lymphocytes of individuals sensitized against antigen D

Tibor Bakács, Gábor Ringwald, Ilona Jókuti

Journal:

Immunology Letters

Year:

1982

Language:

english

File:

PDF, 233 KB

english, 1982

5

Inhibition of the anti-D antibody-dependent cellular cytotoxicity against O,Rh-positive (R1R2) erythrocytes by O,Rh-negative (rr) competitor cells

Tibor Bakács, Gábor Ringwald, Károly Wedrödy

Journal:

Immunology Letters

Year:

1982

Language:

english

File:

PDF, 251 KB

english, 1982

6

Haemolysis mediated by anti-D monoclonal antibodies in direct and cold target competition ADCC assays

Tibor Bakács, Belinda M. Kumpel, Gábor Tusnády

Journal:

Immunology Letters

Year:

1992

Language:

english

File:

PDF, 614 KB

english, 1992

7

Comparison of lysis of bromelain and papain treated red cells in ADCC assays

Belinda M. Kumpel, Tibor Bakács

Journal:

Immunology Letters

Year:

1992

Language:

english

File:

PDF, 232 KB

english, 1992

8

Red-cell bound anti-A is more efficient than anti-B in competition for fluid phase complement

Tibor Bakács, Gabor Tusnády, Zsuzsa Végh, Anthony H. Merry, Zsuzsa Kertész, Eva Klein

Journal:

Immunology Letters

Year:

1993

Language:

english

File:

PDF, 355 KB

english, 1993

9

Interactions in the complement-mediated lysis of blood group AB erythrocytes sensitized simultaneously with anti-A and anti-B monoclonal antibodies

Tibor Bakács, Zsuzsa Végh, Anthony H. Merry, Robert B. Sim, László Varga, Zsuzsa Kertész, Gábor Tusnády, Eva Klein

Journal:

Immunology Letters

Year:

1993

Language:

english

File:

PDF, 650 KB

english, 1993

10

Comparison of the ability of red cells sensitized with a bispecific anti-D × anti-FcγRIII Fab fragment to activate human K cells and peritoneal macrophages through FcγRIII

Tibor Bakács, Andrew G. Hadley, Belinda M. Kumpel, David M. Segal, Ferenc Banhidy

Journal:

Immunology Letters

Year:

1994

Language:

english

File:

PDF, 439 KB

english, 1994

11

Enhanced K-cell activity in the peripheral blood of patients with malignant disease

Tibor Bakács, Pál Czanik, Ian Kimber, Gábor Ringwald, Michael Moore, Erzsébet Ábrahám

Journal:

Cancer Immunology, Immunotherapy

Year:

1984

Language:

english

File:

PDF, 443 KB

english, 1984

12

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo

M. Belen Moreno, Julie A. Titus, Michael S. Cole, J. Yun Tso, Nhat Le, Chang H. Paik, Tibor Bakács, Charles M. Zacharchuk, David M. Segal, John R. Wunderlich

Journal:

Cancer Immunology, Immunotherapy

Year:

1995

Language:

english

File:

PDF, 946 KB

english, 1995

13

Quantitative comparison of direct and cold-target competition assay in monocyte- and complement-mediated lysis of sensitized erythrocytes

Tibor Bakács, Klára Tótpál, Gábor Ringwald, Eva Klein

Journal:

Immunology Letters

Year:

1987

Language:

english

File:

PDF, 442 KB

english, 1987

14

Intentional coinfection of patients with HCV infection using avian infection bursal disease virus

Tibor Bakács, Jitendra N. Mehrishi

Journal:

Year:

2002

Language:

english

File:

PDF, 46 KB

english, 2002

15

K cell mediated haemolysis: influence of large numbers of unsensitized cells on the antibody-dependent lysis of anti-D-sensitized erythrocytes by human lymphocytes

Tibor Bakács, Ian Kimber, Gabor Ringwald, Michael Moore

Journal:

British Journal of Haematology

Year:

1984

Language:

english

File:

PDF, 476 KB

english, 1984

16

Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?

Tibor Bakács, Jitendra N Mehrishi

Journal:

Year:

2010

Language:

english

File:

PDF, 681 KB

english, 2010

17

The Role of Antibody Density in the Immune Lysis of Sensitised Erythrocytes: A Mathematical Appreciation

Tibor Bakács, Gábor Ringwald, Tünde Léránth, Ian Kimber

Journal:

Year:

1989

Language:

english

File:

PDF, 1.21 MB

english, 1989

18

Characterization of cytotoxic human lymphocyte subpopulations: The role of Fc-receptor-carrying cells

Tibor Bakacs, Peter Gergely, Eva Klein

Journal:

Cellular Immunology

Year:

1977

Language:

english

File:

PDF, 672 KB

english, 1977

19

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood: I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations

Eitan Yefenof, Tibor Bakacs, Lena Einhorn, Ingemar Ernberg, George Klein

Journal:

Cellular Immunology

Year:

1978

Language:

english

File:

PDF, 536 KB

english, 1978

20

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood: II. Epstein-Barr virus studies

Lena Einhorn, Michael Steinitz, Eitan Yefenof, Ingemar Ernberg, Tibor Bakacs, George Klein

Journal:

Cellular Immunology

Year:

1978

Language:

english

File:

PDF, 907 KB

english, 1978

21

Reduction in High Blood Tumor Necrosis Factor-α Levels After Manipulative Therapy in 2 Cervicogenic Headache Patients

Gábor Ormos, J.N. Mehrishi, Tibor Bakács

Journal:

Journal of Manipulative and Physiological Therapeutics

Year:

2009

Language:

english

File:

PDF, 382 KB

english, 2009

22

Examination of the value of treatment of decompensated viral hepatitis patients by intentionally coinfecting them with an apathogenic IBDV and using the lessons learnt to seriously consider treating patients infected with HIV using the apathogenic hepatitis G virus

Tibor Bakács, J.N. Mehrishi

Journal:

Year:

2004

Language:

english

File:

PDF, 140 KB

english, 2004

23

Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials

Jitendra N. Mehrishi, Miklós Szabó, Tibor Bakács

Journal:

Year:

2007

Language:

english

File:

PDF, 837 KB

english, 2007

24

HIV and hepatitis G virus/GB virus C co-infection: beneficial or not?

JN Mehrishi, Tibor Bakács

Journal:

The Lancet Infectious Diseases

Year:

2005

Language:

english

File:

PDF, 37 KB

english, 2005

25

HIV and GB virus C coinfection – Authors' reply

JN Mehrishi, Tibor Bakács

Journal:

The Lancet Infectious Diseases

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

26

Cold target competition analysis of the classical activation pathway of complement-mediated cytotoxicity: A non-interaction model for competing lysis

Gábor Tusnády, Anna Erdei, Tibor Bakács

Journal:

Molecular Immunology

Year:

1992

Language:

english

File:

PDF, 1003 KB

english, 1992

27

An indirect effect of an antibody on complement deposition and lysis of differently sensitized surrounding cells

Tibor Bakács, Hans U. Lutz, Gábor Tusnády, László Varga, Anthony H. Merry, Robert R. Sim

Journal:

Molecular Immunology

Year:

1994

Language:

english

File:

PDF, 1.32 MB

english, 1994

28

Ipilimumab (Yervoy) and the TGN1412 catastrophe

Tibor Bakacs, Jitendra N. Mehrishi, Ralph W. Moss

Journal:

Year:

2012

Language:

english

File:

PDF, 470 KB

english, 2012

29

Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)

Tibor Bakacs, Jitendra N. Mehrishi, Miklós Szabó, Ralph W. Moss

Journal:

Pharmacological Research

Year:

2012

Language:

english

File:

PDF, 286 KB

english, 2012

30

A novel method of CD34+ cell separation from umbilical cord blood

Mehrishi, J.N., Bakács, Tibor

Journal:

Transfusion (Wiley)

Year:

2013

Language:

english

File:

PDF, 217 KB

english, 2013

31

Informations

Slavin, Shimon, Moss, Ralph W., Bakacs, Tibor

Journal:

Year:

1976

Language:

french

File:

PDF, 681 KB

french, 1976

32

Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity

Slavin, Shimon, Moss, Ralph W., Bakacs, Tibor

Journal:

Pharmacological Research

Year:

2014

Language:

english

File:

PDF, 427 KB

english, 2014

33

SUFFICIENT TO RECOGNIZE SELF TO ATTACK NON-SELF: BLUEPRINT FOR A ONE-SIGNAL T CELL MODEL

SZABADOS, TAMÁS, BAKÁCS, TIBOR

Journal:

Journal of Biological System

Year:

2011

Language:

english

File:

PDF, 360 KB

english, 2011

34

Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiency

Bakacs, Tibor, Mehrishi, Jitendra N.

Journal:

Year:

2015

Language:

english

File:

PDF, 239 KB

english, 2015

35

A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma

Bakács, Tibor, Lee, Jaetae, Moreno, M. Belen, Zacharchuk, Charles M., Cole, Michael S., Yun Tso, J., Paik, Chang H., Ward, Jerrold M., Segal, David M.

Journal:

International Immunology

Year:

1995

Language:

english

File:

PDF, 3.23 MB

english, 1995

36

Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies

Hornyák, Ákos, Lipinski, Kai S., Bakonyi, Tamás, Forgách, Petra, Horváth, Ernő, Farsang, Attila, Hedley, Susan J., Palya, Vilmos, Bakács, Tibor, Kovesdi, Imre

Journal:

The Journal of Gene Medicine

Year:

2015

Language:

english

File:

PDF, 1.00 MB

english, 2015

37

Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2

Kleef, Ralf, Moss, Ralph, Szasz, A. Marcell, Bohdjalian, Arthur, Bojar, Hans, Bakacs, Tibor

Journal:

Integrative Cancer Therapies

Year:

2018

Language:

english

File:

PDF, 307 KB

english, 2018

38

MiStImm: an agent-based simulation tool to study the self-nonself discrimination of the adaptive immune response

Kerepesi, Csaba, Bakács, Tibor, Szabados, Tamás

Journal:

Theoretical Biology and Medical Modelling

Year:

2019

Language:

english

File:

PDF, 2.22 MB

english, 2019

39

Exploiting autoimmunity unleashed by low‐dose immune checkpoint blockade to treat advanced cancer

Bakacs, Tibor, Moss, Ralph W., Kleef, Ralf, Szasz, Marcell A., Anderson, Colin C.

Journal:

Scandinavian Journal of Immunology

Year:

2019

Language:

english

File:

PDF, 238 KB

english, 2019

40

Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies

Kerepesi, Csaba, Bakacs, Tibor, Moss, Ralph W., Slavin, Shimon, Anderson, Colin C.

Journal:

Cancer Immunology, Immunotherapy

Year:

2020

File:

PDF, 1.03 MB

2020